ATLAS Study Group[Corporate Author] - Search Results

Year	Number of Results
2003	2
2004	1
2006	1
2007	1
2008	4
2009	3
2011	1
2024	0

1

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J, Dougados M, Reveille JD, Wong RL, Kupper H, Davis JC Jr; ATLAS Study Group. van der Heijde D, et al. Arthritis Rheum. 2006 Jul;54(7):2136-46. doi: 10.1002/art.21913. Arthritis Rheum. 2006. PMID: 16802350 Free article. Clinical Trial.

2

Titration of Insulin Glargine in Patients with Type 2 Diabetes Mellitus in Asia: Physician- Versus Patient-Led? Rationale of the Asian Treat to Target Lantus Study (ATLAS).

ATLAS Study Group. ATLAS Study Group. Diabetes Technol Ther. 2011 Jan;13(1):67-72. doi: 10.1089/dia.2010.0170. Diabetes Technol Ther. 2011. PMID: 21175274 Clinical Trial.

3

Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis.

van der Heijde DM, Revicki DA, Gooch KL, Wong RL, Kupper H, Harnam N, Thompson C, Sieper J; ATLAS Study Group. van der Heijde DM, et al. Arthritis Res Ther. 2009;11(4):R124. doi: 10.1186/ar2790. Epub 2009 Aug 17. Arthritis Res Ther. 2009. PMID: 19686597 Free PMC article. Clinical Trial.

4

Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.

van der Heijde D, Salonen D, Weissman BN, Landewé R, Maksymowych WP, Kupper H, Ballal S, Gibson E, Wong R; Canadian (M03-606) study group; ATLAS study group. van der Heijde D, et al. Arthritis Res Ther. 2009;11(4):R127. doi: 10.1186/ar2794. Epub 2009 Aug 24. Arthritis Res Ther. 2009. PMID: 19703304 Free PMC article.

5

Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS).

Revicki DA, Luo MP, Wordsworth P, Wong RL, Chen N, Davis JC Jr; ATLAS Study Group. Revicki DA, et al. J Rheumatol. 2008 Jul;35(7):1346-53. Epub 2008 May 15. J Rheumatol. 2008. PMID: 18484692 Clinical Trial.

6

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial.

van der Heijde D, Schiff MH, Sieper J, Kivitz AJ, Wong RL, Kupper H, Dijkmans BA, Mease PJ, Davis JC Jr; ATLAS Study Group. van der Heijde D, et al. Ann Rheum Dis. 2009 Jun;68(6):922-9. doi: 10.1136/ard.2007.087270. Epub 2008 Aug 13. Ann Rheum Dis. 2009. PMID: 18701556 Free PMC article. Clinical Trial.

7

High- versus low-dose angiotensin converting enzyme inhibitor therapy in the treatment of heart failure: an economic analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial.

Schwartz JS, Wang YR, Cleland JG, Gao L, Weiner M, Poole-Wilson PA; ATLAS Study Group. Schwartz JS, et al. Am J Manag Care. 2003 Jun;9(6):417-24. Am J Manag Care. 2003. PMID: 12816171 Free article. Clinical Trial.

8

Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis.

van der Heijde D, Pangan AL, Schiff MH, Braun J, Borofsky M, Torre J, Davis JC Jr, Wong RL, Kupper H, Collantes E; ATLAS Study Group. van der Heijde D, et al. Ann Rheum Dis. 2008 Sep;67(9):1218-21. doi: 10.1136/ard.2007.082529. Epub 2007 Dec 4. Ann Rheum Dis. 2008. PMID: 18056755 Free PMC article. Clinical Trial.

9

Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.

Majumdar SR, McAlister FA, Cree M, Chang WC, Packer M, Armstrong PW; ATLAS Study Group. Majumdar SR, et al. Clin Ther. 2004 May;26(5):694-703. doi: 10.1016/s0149-2918(04)90069-0. Clin Ther. 2004. PMID: 15220013

10

Evaluation of the patient acceptable symptom state as an outcome measure in patients with ankylosing spondylitis: data from a randomized controlled trial.

Dougados M, Luo MP, Maksymowych WP, Chmiel JJ, Chen N, Wong RL, Davis JC Jr, van der Heijde D; ATLAS STUDY GROUP. Dougados M, et al. Arthritis Rheum. 2008 Apr 15;59(4):553-60. doi: 10.1002/art.23527. Arthritis Rheum. 2008. PMID: 18383418 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year